title: Protease inhibitors enhance levodopa effects in Parkinson's disease.
authors.forename: D
authors.initials: D
authors.lastname: Caparros-Lefebvre
authors.forename: A
authors.initials: A
authors.lastname: Lannuzel
authors.forename: F
authors.initials: F
authors.lastname: Tiberghien
authors.forename: M
authors.initials: M
authors.lastname: Strobel
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000378:metabolism*; D004357:Drug Synergism; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D019469:Indinavir / Q000494:pharmacology*; D007980:Levodopa / Q000009:adverse effects* / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D017320:HIV Protease Inhibitors; D007980:Levodopa; D019469:Indinavir